Insider Trading & Ownership of Kendra Adams

Location
Watertown, MA
Summary
The estimated net worth of Kendra Adams is at least $727,835 dollars as of 18 Feb 2026. Kendra Adams is the Chief Financial Officer of C4 Therapeutics, Inc. and owns shares of C4 Therapeutics, Inc. (CCCC) stock worth about $727.8K.
Signature
/s/ Shagha Russell, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Kendra Adams and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Kendra Adams has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $727,835.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: C4 Therapeutics, Inc. ($727,835).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Kendra Adams

Insider Transactions Reported by Kendra Adams:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .